Is NCT02299921 recruiting in Aurora, CO?

Yes, NCT02299921 is currently recruiting participants at its Aurora, CO location. This infection clinical trial is actively enrolling qualified participants.

How do I join the infection clinical trial in Aurora?

To join this clinical trial in Aurora, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Aurora clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Infection Clinical Trial in Aurora, CO

About This Infection Study in Aurora

This study plans to learn more about people who are sick in the hospital with a lung infection, or respiratory failure. Respiratory failure, or severe lung failure, is a life-threatening disease. When it happens, the lungs have trouble carrying out their normal function of getting oxygen into the blood, and removing carbon dioxide from the body. Investigators are conducting this study to see what drinking too much alcohol, using tobacco products, or using drugs (both legal and illegal) may do to lung infections and respiratory failure. Subjects are asked to be in this research study because they are thought to have a lung infection and may also have respiratory failure. Alcohol, tobacco, and drug use have been linked to lung infections, respiratory failure, and even death, but the reasons for this aren't known. People who use unhealthy amounts of alcohol, tobacco, and or drugs may be more at risk for lung infections, and for severe complications due to lung infection. Subject participation is important whether or not you use alcohol and or drugs.

Sponsor: University of Colorado, Denver

Who Can Participate

Inclusion Criteria

Specific Aim 1: Adult medical ICU patients admitted to the University of Colorado Hospital for a primary respiratory problem, and who are expected to require ICU care ≥48 hrs

Specific Aim 2: (1) Adult medical ICU patients with respiratory failure (due to underlying lung pathology) and who require endotracheal intubation and mechanical ventilation. (2) Adult medical and other ICU patients with respiratory failure, not related to a lung condition, and who require endotracheal intubation and mechanical ventilation. (3) Adult ICU patients previously admitted to the University of Colorado Hospital for a primary respiratory problem, and who required care ≥48 hrs.

Exclusion Criteria

, Specific Aim 1 and 2:

Patients who are expected to require ICU care \<48 hrs

Patients admitted to the ICU who are not ICU status (being housed for space issues)

Patient is unlikely to survive 48 hours

Patient is on comfort care (hospice measures)

Patients less than 18 or greater than 90 years of age

Patient is a prisoner

ICU attending declines enrollment of patient

Patients who are pregnant

Patients who have significant anemia, defined as Hgb\<8% or Hct\<24%, or who have evidence of active bleeding. For bronchoscopy portion of Specific Aim 2.

Patients who are on either a fraction of inspired oxygen inspired oxygen fraction (FiO2)\>80% or positive end expiratory pressure (PEEP) \>10 cm H20

Patients with platelets less than 30,000(chronically)

Patients who are expected to undergo a spontaneous breathing trial within the next 4 hours

Patients with an order or plan to extubate in the next 4 hours

Patients who have an endotracheal tube (ETT) \<7.5 F

Patients who are currently dangerously agitated

Pregnant women Exclusion criteria (outpatients ONLY for SA2 (3)):

Patients who required ICU care \<48 hrs

Patients less than 18 or greater than 90 years of age

Patient is a prisoner

Patients who are pregnant

Residency \> 40 miles from UCH clinics

non-English or non-Spanish speaking

Inability to perform study procedures (i.e. physical disability)

unable to perform pulmonary function testing

diagnosis of chronic pulmonary disease (e.g. COPD)

diagnosis of chronic neurodegenerative disease or severe dementia

history of anoxic or traumatic brain injury

prior ICU hospitalization at a non-UCH facility.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Aurora?

Yes, this clinical trial (NCT02299921) has an active research site in Aurora, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Infection Treatment Options in Aurora, CO

If you're searching for infection treatment options in Aurora, CO, this clinical trial (NCT02299921) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all infection clinical trials near you to find additional studies recruiting in your area.

Infection Clinical Trial in Aurora, CO

Expert Care in Aurora

IRB Approved

No-Cost Care

Apply for This Aurora Location

Why Participate?

Simple Process